Literature DB >> 23595855

[Intraoperative chemotherapy after radical pleurectomy or extrapleural pneumonectomy].

M Ried1, H-S Hofmann.   

Abstract

Trimodality treatment including induction and/or adjuvant chemotherapy, surgical resection and in some cases radiotherapy offers a curative intention in selected patients with pleural malignancies (malignant pleural mesothelioma, thymoma with pleural spread). Nevertheless, locoregional tumor recurrence mainly limits the outcome and the quality of life. A few years ago an additional intraoperative chemotherapy perfusion was developed in order to improve local tumor control and prognosis after surgical resection in a multimodality treatment setting. Cytoreductive surgery with the purpose of a macroscopic complete resection could be achieved by radical pleurectomy or extrapleural pneumonectomy. The concept, techniques and perioperative management of this additional treatment option are presented along with a detailed review of the recent literature.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23595855     DOI: 10.1007/s00104-012-2433-4

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  34 in total

1.  Cytoreductive surgery combined with intraoperative hyperthermic intrathoracic chemotherapy for stage I malignant pleural mesothelioma.

Authors:  S van Ruth; P Baas; R L M Haas; E J Th Rutgers; V J Verwaal; F A N Zoetmulder
Journal:  Ann Surg Oncol       Date:  2003-03       Impact factor: 5.344

2.  Pleurectomy/decortication is superior to extrapleural pneumonectomy in the multimodality management of patients with malignant pleural mesothelioma.

Authors:  Loïc Lang-Lazdunski; Andrea Bille; Rohit Lal; Paul Cane; Emma McLean; David Landau; Jeremy Steele; James Spicer
Journal:  J Thorac Oncol       Date:  2012-04       Impact factor: 15.609

Review 3.  [Cytoreductive surgery and hyperthermic intrathoracic chemotherapy perfusion].

Authors:  H-S Hofmann; K Wiebe
Journal:  Chirurg       Date:  2010-06       Impact factor: 0.955

4.  Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients.

Authors:  D J Sugarbaker; R M Flores; M T Jaklitsch; W G Richards; G M Strauss; J M Corson; M M DeCamp; S J Swanson; R Bueno; J M Lukanich; E H Baldini; S J Mentzer
Journal:  J Thorac Cardiovasc Surg       Date:  1999-01       Impact factor: 5.209

5.  Hyperthermic intraoperative pleural cisplatin chemotherapy extends interval to recurrence and survival among low-risk patients with malignant pleural mesothelioma undergoing surgical macroscopic complete resection.

Authors:  David J Sugarbaker; Ritu R Gill; Beow Y Yeap; Andrea S Wolf; Marcelo C DaSilva; Elizabeth H Baldini; Raphael Bueno; William G Richards
Journal:  J Thorac Cardiovasc Surg       Date:  2013-02-21       Impact factor: 5.209

6.  Multimodal treatment for stage IVA thymoma: a proposable strategy.

Authors:  Ottavio Rena; Tommaso Claudio Mineo; Caterina Casadio
Journal:  Lung Cancer       Date:  2011-10-24       Impact factor: 5.705

7.  Cytoreductive surgery and hyperthermic intrathoracic chemotherapy perfusion for malignant pleural tumours: perioperative management and clinical experience.

Authors:  Michael Ried; Tobias Potzger; Nico Braune; Reiner Neu; York Zausig; Berthold Schalke; Claudius Diez; Hans-Stefan Hofmann
Journal:  Eur J Cardiothorac Surg       Date:  2012-08-10       Impact factor: 4.191

8.  Induction of apoptosis by intrapleural perfusion hyperthermo-chemotherapy for malignant pleural mesothelioma.

Authors:  Yasunori Matsuzaki; Masaki Tomita; Tetsuya Shimizu; Masaki Hara; Takanori Ayabe; Toshio Onitsuka
Journal:  Ann Thorac Cardiovasc Surg       Date:  2008-06       Impact factor: 1.520

9.  Prevention, early detection, and management of complications after 328 consecutive extrapleural pneumonectomies.

Authors:  David J Sugarbaker; Michael T Jaklitsch; Raphael Bueno; William Richards; Jeanne Lukanich; Steven J Mentzer; Yolonda Colson; Phillip Linden; Michael Chang; Leah Capalbo; Elizabeth Oldread; Siyamek Neragi-Miandoab; Scott J Swanson; Lambros S Zellos
Journal:  J Thorac Cardiovasc Surg       Date:  2004-07       Impact factor: 5.209

10.  Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients.

Authors:  Raja M Flores; Harvey I Pass; Venkatraman E Seshan; Joseph Dycoco; Maureen Zakowski; Michele Carbone; Manjit S Bains; Valerie W Rusch
Journal:  J Thorac Cardiovasc Surg       Date:  2008-02-14       Impact factor: 5.209

View more
  1 in total

1.  Is Hyperthermic Intrathoracic Chemotherapy (HITHOC) Safe and Efficacious in Masaoka-Koga Stage-IVA Thymoma? A Pilot Study.

Authors:  Arvind Kumar; Mohan Venkatesh Pulle; Belal Bin Asaf; Harsh Vardhan Puri; Aparna Kumar; Sukhram Bishnoi
Journal:  Indian J Surg Oncol       Date:  2021-09-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.